Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease

CardioVascular and Interventional Radiology

Volumn 33, Issue 3, 2010, Pages 509-512

  Weintraub, Joshua L ^a   Belanger, Adam R ^a   Sung, Chris C ^a   Stangl, P Anondo ^a   Nowakowski, F Scott ^a   Lookstein, Robert L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Graft versus host disease; Intra arterial; Secondary therapy; Steroid therapy

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; MALE; PRIORITY JOURNAL; STEROID THERAPY; SURVIVAL TIME; TOTAL PARENTERAL NUTRITION;

ACUTE DISEASE; ADULT; AGED; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953137750     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-009-9792-3     Document Type: Article

References (10)

1. Couriel D, Caldera H, Champlin R, Komanduri K (2004) Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 101:1936-1946
2. Ball LM, Egeler RM, EBMT Paediatric Working Party (2008) Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 41 (Suppl 2): S58-S64
3. Quellmann S, Schwarzer G, Hubel K, Greb A, Engert A, Bohlius J (2008) Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation. Cochrane Database Syst Rev 3: CD004885
4. Messina C, Faraci M, de Fazio V et al (2008) Prevention and treatment of acute GvHD. Bone Marrow Transplant 41 (Suppl 2): S65-S70
5. Sato T, Sakamaki S, Nagaoka Y et al (1997) Intra-mesenteric artery steroid administration relieved severe refractory gastrointestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient. Am J Hematol 56:277-280
6. Shapira MY, Bloom AI, Or R et al (2002) Intra-arterial catheter directed therapy for severe graft-versus-host disease. Br J Haematol 119:760-764
7. Nakai K, Tajima K, Tanigawa N et al (2004) Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versushost disease with the evaluation of angiography. Bone Marrow Transplant 33:1231-1233
8. Tfayli A, Selby G, Maqbool F, Bierbaum W, Hamadani M (2006) Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease. Am J Hematol 81:959-962
9. Shapira MY, Bloom AI, Or R et al (2008) Intra-arterial catheter directed immunosuppressive therapy for steroid resistant or dependent graft vs host disease (GVHD). Biol Blood Marrow Transplant 14(S2):138-139
10. Bloom AI, Shapira MY, Or R et al (2004) Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial. Clin Ther 26:407-414